Inhibition of adherence and cytotoxicity by circulating immune complexes formed in experimental filariasis

Parasite Immunology
|January 1, 1982
PubMed

Insights

Immune complexes in jird serum block the immune system's ability to attack Brugia pahangi microfilariae. This immune evasion may explain why microfilariae persist in infected jirds.

Area of Science:

  • Immunology
  • Parasitology
  • Cell Biology

Background:

  • Brugia pahangi microfilariae cause persistent infections.
  • The host immune response to microfilariae is not fully understood.

Purpose of the Study:

  • To investigate the interaction between jird peritoneal exudate cells (PEC) and Brugia pahangi microfilariae.
  • To determine the role of serum factors and circulating immune complexes in modulating this interaction.

Main Methods:

  • Incubation of normal jird PEC with microfilariae in the presence of antisera.
  • Heat inactivation and serum readdition experiments.
  • Precipitation of circulating immune complexes (CICs) using polyethylene glycol (PEG).
  • Assessment of adherence and cytotoxicity of PEC towards microfilariae.
  • Evaluation of complement consumption by CICs.

Main Results:

  • Normal jird PEC adhered to and showed cytotoxicity against microfilariae when incubated with antimicrofilarial antisera.
  • Heat inactivation of antisera reduced adherence and cytotoxicity; fresh serum partially restored these reactions.
  • Macrophages were the primary adherent cells.
  • Circulating immune complexes from infected jirds significantly inhibited PEC adherence and cytotoxicity.
  • Complement consumption did not explain the inhibitory effect of CICs.

Conclusions:

  • Circulating immune complexes in infected jirds inhibit the cellular immune response against Brugia pahangi microfilariae.
  • This inhibition of adherence and cytotoxicity by CICs may prevent microfilariae trapping in vivo.
  • Immune complexes likely contribute to the persistence of microfilaraemia in jirds.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...